Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Chronic kidney disease (CKD)

Chronic kidney disease (CKD)

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Chronic kidney disease (CKD)

10 trials tracked for Chronic kidney disease (CKD): 6 in phase 3 or 4 and 5 with published results. The most-cited published study has 248 citations.

10Trials tracked
6Phase 3 & 4
0Recruiting
5With published results
Phase distribution
Phase 4 3 Phase 3 3 Phase 2 1 Other / NA 3
  1. Phase 4 Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM) Completed · 248 cited
  2. Phase 3 Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa Completed · 48 cited
  3. Phase 3 A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis Completed · 48 cited
  4. Phase 4 Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis Completed · 21 cited
  5. Phase 4 Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus Completed · 3 cited
  6. Phase 3 A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL) Completed
Show 4 more trials
  1. Phase 2 Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function Completed
  2. N/A Medication Adherence Given Individual SystemCHANGE(TM) in Advancing Nephropathy (MAGICIAN) Pilot Study Completed
  3. N/A Impact of Vitamin D Therapies on Chronic Kidney Disease Completed
  4. N/A Effects of Personalized Actionable Connected Extensible (PACE) Interventions Among Patients With Chronic Kidney Disease Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
MASLD is associated with higher CKD prevalence and accelerated renal impairment progression
Nephrology Meta-analysis
MASLD is associated with higher CKD prevalence and accelerated renal impairment progression Liver disease and fatty liver are linked to kidney damage
This meta-analysis examines the relationship between metabolic dysfunction-associated steatotic liver disease (MASLD) and chronic kidney dis…
People with fatty liver disease face a higher risk of developing chronic kidney disease, especially as liver scarring worsens.
Aug 6, 2026